Macabinta, Gemma .

HRN: 15-55-09  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2025
CEFUROXIME 500MG (TAB)
04/06/2025
04/12/2025
ORAL
500mg
2 Times A Day
NSVD, Intransit Delivery, First Degree Perineal Laceration
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: